يعرض 241 - 260 نتائج من 21,342 نتيجة بحث عن '(( ((significant gap) OR (significant inter)) decrease ) OR ( significant decrease decrease ))', وقت الاستعلام: 0.51s تنقيح النتائج
  1. 241
  2. 242
  3. 243
  4. 244
  5. 245
  6. 246

    Summary map of all contacts with statistically significant SVM classifications. حسب Alexander P. Rockhill (6053618)

    منشور في 2024
    "…The middle row shows the directionality of spectral change for these significant SVM clusters during number trial conditions versus inter-trial intervals. …"
  7. 247

    Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers. حسب Luqiong Liu (11537092)

    منشور في 2024
    "…(<b>C</b>) Y-27632 collaborated with BA to alleviate the decrease in FD-4 flux in LPS-induced Caco2 cells on day 22. …"
  8. 248
  9. 249
  10. 250
  11. 251
  12. 252

    Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> حسب Razia Rashid Rahil (22772495)

    منشور في 2025
    "…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …"
  13. 253
  14. 254
  15. 255

    Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx حسب Tengxiang Zhao (20749475)

    منشور في 2025
    "…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…"
  16. 256

    Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx حسب Tengxiang Zhao (20749475)

    منشور في 2025
    "…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…"
  17. 257
  18. 258
  19. 259
  20. 260